This article was originally published in The Gray Sheet
AngioDynamics subsidiary Rita Medical pays $2,750 to the U.S. government to settle allegations that it traded with an entity in Iran between October 2002 and January 2003 without disclosing the activities to the Treasury Department's Office of Foreign Assets Control, a violation of the Iranian Transactions Regulations. AngioDynamics bought radiofrequency ablation device maker Rita for $220 million in January (1"The Gray Sheet" Dec. 4, 2006, p. 10). Another device maker, EP MedSystems, paid $277,000 to settle similar charges in 2006 and earlier this year
You may also be interested in...
AngioDynamics will gain immediate access to the targeted tumor ablation market and will fill out its vascular access business in a $220 mil. acquisition of Rita Medical
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.